Delivery Order 36F79721D0213-36C26123N0723
Award Date 7/11/23
Potential Completion Date 9/11/23
Potential Value $32K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Berkeley Heights, NJ 07922, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Veterans Affairs, Veterans Integrated Service Network 20, awarded a $173,088.68 delivery order contract to Amneal Pharmaceuticals of New York, LLC for the supply of Xyrem (sodium oxybate) oral solution. The contract, issued on November 1, 2024, under the GSA Multiple Award Schedule for Pharmaceuticals and Drugs (FSS-61-IB), carries a firm fixed price and requires completion by October 31, 2025, with performance taking place in Normandy, Missouri. This delivery order was...
- This federal contract award is for the delivery of the pharmaceutical product XYREM to the Veterans Integrated Service Network 21 (VISN 21) of the U.S. Department of Veterans Affairs (VA). The contract was awarded to Jazz Pharmaceuticals, Inc., a global biopharmaceutical company specializing in specialty medications for neurological and sleep disorders. The contract has a ceiling value of $17,785.80 and is a firm fixed-price delivery order with a performance period ending on January 22, 2024. It...
- This federal contract award was issued by the Veterans Integrated Service Network 6 (VISN 6) of the Department of Veterans Affairs (VA) to Jazz Pharmaceuticals, Inc. as a prime contractor. The $84,429 firm fixed-price delivery order is under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract, which allows the VA to efficiently procure needed specialty medications. The contract is for the delivery of pharmaceutical products such as Xyrem, Xywav, and sodium oxybate...
- This is a federal contract award to Jazz Pharmaceuticals, Inc. by the Department of Veterans Affairs (VA) for the delivery of the specialty pharmaceuticals Xyrem (sodium oxybate) and Xywav (calcium/magnesium/potassium/sodium oxybate). The contract is a firm fixed price delivery order under Jazz Pharmaceuticals' existing Federal Supply Schedule contract for Pharmaceuticals and Drugs with the VA. The contract has a ceiling value of $904,077.91 and a period of performance through October 31,...
- This federal contract award was issued by the Veterans Integrated Service Network 5 (VISN 5) of the U.S. Department of Veterans Affairs (VA) to Harmony Biosciences LLC, a pharmaceutical company specializing in rare neurological diseases and sleep disorders. The $10,170 firm-fixed-price delivery order is for WAKIX 17.8 MG, a medication used to treat excessive daytime sleepiness and cataplexy in adult narcolepsy patients. The contract is issued against Harmony Biosciences' General Services...
- This is a contract award to Jazz Pharmaceuticals, Inc. by the Department of Veterans Affairs Veterans Health Administration (VA VHA) for the delivery of the specialty pharmaceutical Xyrem. The contract is a Blanket Purchase Agreement (BPA) Call and a Federal Supply Schedule (FSS) contract under the Pharmaceuticals and Drugs schedule, allowing the VA to efficiently procure needed medications. The total potential value of the contract is $180,137.37, with no set-aside designation. Jazz...
- This is a federal contract award made by the Veterans Health Administration (VHA) to Jazz Pharmaceuticals, Inc., a global biopharmaceutical company, for the delivery of the medication XYWAV 500 MG ORAL SOLUTION. The contract is a firm fixed price Delivery Order issued under Jazz Pharmaceuticals' Pharmaceuticals and Drugs Federal Supply Schedule (FSS) contract with a ceiling value of $10,229.64. The contract has an ultimate completion date of July 31, 2024. No set-aside designation was used. This...
- This federal contract award was made by the Veterans Health Administration, a component of the U.S. Department of Veterans Affairs, to Harmony Biosciences LLC, a pharmaceutical company specializing in rare neurological diseases and sleep disorders. The contract is a delivery order with a firm fixed price of $10,418.14 and a completion date of August 22, 2025. It is part of a larger Blanket Purchase Agreement (BPA) valued at $25,000,000 and an Indefinite-Delivery Indefinite-Quantity (IDIQ)...
- This federal contract award was issued by the Department of Veterans Affairs (VA) to Harmony Biosciences LLC, a pharmaceutical company specializing in medications for rare neurological diseases and sleep disorders. The award was for the delivery of WAKIX 17.8 mg tablets, a drug used to treat excessive daytime sleepiness and cataplexy in adult narcolepsy patients. The contract is a Firm Fixed Price Delivery Order under Harmony Biosciences' Federal Supply Schedule (FSS-61-IB) for Pharmaceuticals...
- This is a federal contract award to Jazz Pharmaceuticals, Inc. for the delivery of specialty pharmaceutical products, including Xyrem, Xywav, and sodium oxybate, to the U.S. Department of Veterans Affairs (VA). The contract is a delivery order under Jazz Pharmaceuticals' Pharmaceuticals and Drugs Federal Supply Schedule (FSS) contract with the General Services Administration (GSA). The contract has a ceiling value of $132,985.32 and a period of performance through December 31, 2024. The contract...